Research grants are intended to encourage the development of new information that contributes to the understanding of the basic etiology and pathogenesis of cystic fibrosis.
Site Search
Pilot and feasibility awards are intended to support basic science research studies focused on developing and testing new hypotheses in areas relevant to cystic fibrosis.
The Cystic Fibrosis Foundation regularly assesses its key research priorities to ensure we are on track to accomplish our mission to cure CF and to provide people with CF the opportunity to lead long lives. Applicants are encouraged to align submissions to these priorities to maximize their potential for being funded.
Since the launch of the Infection Research Initiative in 2018, the Cystic Fibrosis Foundation has funded more than $100 million in research to improve the detection, diagnosis, treatment, and outcomes of CF-related infections.
The Cystic Fibrosis Foundation practices venture philanthropy by making strategic investments in companies and technologies with the potential to treat or cure CF. We have a proven track record of accelerating the development of innovative therapies through financial investment, customized research materials, and clinical trial infrastructure.
At this age, your child with cystic fibrosis is ready to transition from breast milk or formula to whole milk or a high-calorie supplement. Encourage independent eating. Create a consistent schedule and mealtime expectations.
Caring for a child with CF can be a lot to juggle — from the many medications and daily treatments to the endless doctor's appointments. But I’ve found a system that helps me stay organized and stress-free so that I can focus on what really matters.
We offer awards for cystic fibrosis research and for professional development and training. Below is a list of current and upcoming funding opportunities.
The Cystic Fibrosis Foundation is requesting letters of intent for research projects that aim to use available clinical trials in organ transplantation specimens and/or clinical data to improve knowledge of chronic lung allograft dysfunction pathogenesis and explore new approaches to detection, prevention, monitoring, or treatment of chronic lung allograft dysfunction.